Literature DB >> 25037203

Dopamine receptor signaling in the forebrain: recent insights and clinical implications.

Rodolfo Savica1, Eduardo E Benarroch2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25037203     DOI: 10.1212/WNL.0000000000000719

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  D-Amphetamine Exposure Differentially Disrupts Signaling Across Ontogeny in the Zebrafish.

Authors:  Bradley J Serpa; Jennifer D Bullard; Victoria C Mendiola; Crystal J Smith; Brandon Stewart; Lisa R Ganser
Journal:  Bioelectricity       Date:  2019-06-14

2.  Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.

Authors:  Sarah E Williford; Catherine J Libby; Adetokunbo Ayokanmbi; Arphaxad Otamias; Juan J Gordillo; Emily R Gordon; Sara J Cooper; Matthew Redmann; Yanjie Li; Corinne Griguer; Jianhua Zhang; Marek Napierala; Subramaniam Ananthan; Anita B Hjelmeland
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

3.  Task-Dependent Effects of SKF83959 on Operant Behaviors Associated With Distinct Changes of CaMKII Signaling in Striatal Subareas.

Authors:  Pei-Pei Liu; Chih-Chang Chao; Ruey-Ming Liao
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.